Breaking News - The Fly

Open Search

GANX

Gain Therapeutics

$

()

Gain Therapeutics announces preclinical data on class of allosteric regulators

GANX

12/1/2023 - 08:08am

Gain Therapeutics prices 2.2M shares at $2.005 in public offering

GANX

11/21/2023 - 08:58am

Fly Intel: After-Hours Movers

SYM , FEIM , MOR

…

11/20/2023 - 20:28pm

Gain Therapeutics files to sell common stock, no amount given

GANX

11/20/2023 - 16:04pm

Gain Therapeutics reports Q3 EPS (37c), consensus (45c)

GANX

11/14/2023 - 07:14am

Gain announces dosing of first two subjects in Phase 1 trial of GT-02287

GANX

10/4/2023 - 07:01am

Gain Therapeutics initiated with a Buy at Maxim

GANX

9/12/2023 - 07:34am

Gain Therapeutics announces preclinical data from drug candidate GT-02287

GANX

8/28/2023 - 07:02am

Gain Therapeutics expects cash to fund operations into Q3 of 2024

GANX

8/10/2023 - 07:14am

Gain Therapeutics announces upcoming milestones

GANX

8/10/2023 - 07:14am

Gain Therapeutics reports Q2 EPS (62c), consensus (31c)

GANX

8/10/2023 - 07:13am

Gain announces acceptance of late breaking abstract to present on GT-02287

GANX

8/7/2023 - 07:08am

Gain Therapeutics price target raised to $6 from $5.75 at Chardan

GANX

5/14/2023 - 20:43pm

Gain Therapeutics expects cash to fund operations into 3Q24

GANX

5/12/2023 - 08:08am

Gain Therapeutics reports Q1 EPS (43c), consensus (39c)

GANX

5/12/2023 - 08:07am